M. Kulyk & Associates, LLC Gilead Sciences, Inc. Transaction History

M. Kulyk & Associates, LLC

$446 Million
Q4 2024

A detailed history of M. Kulyk & Associates, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, M. Kulyk & Associates, LLC holds 88,666 shares of GILD stock, worth $8.47 Million. This represents 1.84% of its overall portfolio holdings.

Number of Shares

88,666

Previous 100,467 11.75%

Holding current value

$8.47 Million

Previous $8.42 Million 2.74%

% of portfolio

1.84%

Previous 1.72%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$83.95 - $97.9 $990,693 - $1.16 Million	-11,801 Reduced 11.75%	88,666 $8.19 Million
Q3 2024 Nov 07, 2024	SELL	$66.59 - $83.99 $227,205 - $286,573	-3,412 Reduced 3.28%	100,467 $8.42 Million
Q2 2024 Aug 05, 2024	BUY	$63.15 - $72.88 $925,210 - $1.07 Million	14,651 Added 16.42%	103,879 $7.13 Million
Q1 2024 May 09, 2024	BUY	$71.58 - $87.29 $414,806 - $505,845	5,795 Added 6.95%	89,228 $6.54 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $67,335 - $76,359	-919 Reduced 1.09%	83,433 $6.76 Million
Q3 2023 Nov 07, 2023	BUY	$73.94 - $80.67 $98,857 - $107,855	1,337 Added 1.61%	84,352 $6.32 Million
Q2 2023 Aug 08, 2023	SELL	$76.01 - $86.7 $445,038 - $507,628	-5,855 Reduced 6.59%	83,015 $6.4 Million
Q1 2023 May 08, 2023	BUY	$77.31 - $88.08 $78,933 - $89,929	1,021 Added 1.16%	88,870 $7.37 Million
Q4 2022 Feb 08, 2023	SELL	$62.32 - $89.47 $12,027 - $17,267	-193 Reduced 0.22%	87,849 $7.54 Million
Q3 2022 Nov 07, 2022	BUY	$59.54 - $68.01 $93,596 - $106,911	1,572 Added 1.82%	88,042 $5.43 Million
Q2 2022 Aug 05, 2022	BUY	$57.72 - $65.01 $189,033 - $212,907	3,275 Added 3.94%	86,470 $5.35 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $1.1 Million - $1.38 Million	-19,076 Reduced 18.65%	83,195 $4.95 Million
Q4 2021 Jan 20, 2022	BUY	$64.88 - $73.64 $345,745 - $392,427	5,329 Added 5.5%	102,271 $7.43 Million
Q3 2021 Oct 21, 2021	BUY	$67.69 - $73.03 $320,918 - $346,235	4,741 Added 5.14%	96,942 $6.77 Million
Q2 2021 Jul 21, 2021	BUY	$63.47 - $69.35 $578,973 - $632,610	9,122 Added 10.98%	92,201 $6.35 Million
Q1 2021 Apr 29, 2021	BUY	$60.0 - $68.46 $1.69 Million - $1.93 Million	28,219 Added 51.44%	83,079 $5.37 Million
Q4 2020 Feb 02, 2021	BUY	$56.65 - $64.55 $3.11 Million - $3.54 Million	54,860 New	54,860 $3.2 Million

Others Institutions Holding GILD

# of Institutions

1,993

Shares Held

993M

Call Options Held

10.1M

Put Options Held

8.85M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $120B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of M. Kulyk & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on M. Kulyk & Associates, LLC with notifications on news.

Account

M. Kulyk & Associates, LLC Gilead Sciences, Inc. Transaction History